Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.
about
Immunological aspects of chronic venous disease pathogenesisOxidative Stress and Therapeutic Development in Lung DiseasesEuropean contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1.PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesisVascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.A novel nontoxic inhibitor of the activation of NADPH oxidase reduces reactive oxygen species production in mouse lung.Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans.Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.Models and methods to evaluate transport of drug delivery systems across cellular barriers.Role of oxidative stress in infectious diseases. A review.Endothelial nanomedicine for the treatment of pulmonary disease.Targeted endothelial nanomedicine for common acute pathological conditions.Targeting vascular (endothelial) dysfunction.Endothelial targeting of liposomes encapsulating SOD/catalase mimetic EUK-134 alleviates acute pulmonary inflammation.Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation.Antioxidants in the intensive care unit.Dysregulated Nox4 ubiquitination contributes to redox imbalance and age-related severity of acute lung injury.Targeting superoxide dismutase to endothelial caveolae profoundly alleviates inflammation caused by endotoxin.Targeting therapeutics to endothelium: are we there yet?The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series).Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.Vascular endothelial effects of collaborative binding to platelet/endothelial cell adhesion molecule-1 (PECAM-1).
P2860
Q27011508-EF0F8749-4D25-4D0D-8C6C-3529A203241CQ28390572-18B29043-FDE4-4EEE-8C8D-C567A7092984Q33761211-57BCC4B1-5E7E-4738-A876-69829E580804Q33978310-8131C0CF-F2FA-4887-BE92-9F45BB042764Q36248811-E32772B9-417B-4BD3-B529-DD9E865287CCQ36473318-2556F797-0E47-4A1F-A247-8265798EA834Q36693096-B6FC48AA-0288-4875-9861-8938B432B25EQ36776546-83EE2D10-8024-40E0-9D9A-527332FB33E3Q37134054-2BF24F27-6B18-4D88-AECC-9918C3CEDBF6Q37594660-88544618-4822-432A-A8CA-C04E244EC169Q37627448-0567FB03-5A18-4F24-BE54-E38DEE759E29Q38090568-9203A65C-2E5C-4003-B859-67BA3CE56C74Q38267984-53C98959-4C18-451F-A34F-7F96759962DAQ38598987-43ABD2E8-D08E-4236-B3A4-7A6327034B1CQ38836199-0A71E55C-A183-42F8-A1F0-B08B03E4473FQ41351381-C8EA212A-7471-402C-B607-0161BCB28193Q42160647-6C3022EC-5690-4445-84F3-99CDC931960AQ42346973-92ECF96C-A02C-464E-B347-DD0336273063Q46436039-EC1ED807-D9FA-4BAD-9D9D-BD71815D9BE2Q47240067-7A57B302-E24F-42C5-95B8-839384652A41Q47250590-D52C2159-E05F-411F-AC0B-82A3A636735AQ47675852-E9438121-BB51-41EC-A056-D93B166F1891Q48003088-4A682064-EB23-4B50-931E-470F0CD32010Q48171757-A5DB5195-4188-41BF-A222-1B4B02A85BC2
P2860
Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Antioxidant protection by PECA ...... othelium in vitro and in vivo.
@ast
Antioxidant protection by PECA ...... othelium in vitro and in vivo.
@en
type
label
Antioxidant protection by PECA ...... othelium in vitro and in vivo.
@ast
Antioxidant protection by PECA ...... othelium in vitro and in vivo.
@en
prefLabel
Antioxidant protection by PECA ...... othelium in vitro and in vivo.
@ast
Antioxidant protection by PECA ...... othelium in vitro and in vivo.
@en
P2093
P2860
P1476
Antioxidant protection by PECA ...... othelium in vitro and in vivo.
@en
P2093
Aron B Fisher
Chandra Dodia
Clementina Mesaros
Colin F Greineder
Elizabeth D Hood
Ian A Blair
Jingyan Han
Vladimir R Muzykantov
Vladimir V Shuvaev
P2860
P304
P356
10.1016/J.JCONREL.2012.08.031
P407
P577
2012-09-06T00:00:00Z